Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of H3B-6527 in Participants With Advanced Hepatocellular Carcinoma

NCT02834780 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

128

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Hepatocellular Carcinoma
Hepatocellular Carcinoma
Liver Cancer
Liver Neoplasms
Hepatic Cancer
Hepatic Carcinoma

Interventions

DRUG: H3B-6527

Sponsor

H3 Biomedicine Inc.

Collaborators

[object Object]